Lidocaine Injection, Solution
Product Images NDC 0362-0262

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidocaine (NDC 0362-0262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Septodont, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidocaine Hydrochloride (Lidocaine Hydrochloride)

Chemical structure diagram of Lidocaine Hydrochloride showing its molecular components including the aromatic ring, amide linkage, and ethyl groups attached to the nitrogen, along with the hydrochloride (HCl) part.*

FDA Label Image

Epinephrine (Epinephrine)

Chemical structure diagram of Lidocaine Hydrochloride, showing the molecular arrangement with hydroxyl groups and an amine group attached to the benzene ring.*

FDA Label Image

Principal Display Panel- 1.7 mL Cartridge Carton (2243 2 L50 Cookwaite (us) Septo Pc Gtin)

Packaging label for Lidocaine HCl 2% (34 mg/1.7 mL) (20 mg/mL) and Epinephrine 1:50,000 Injection by Cook-Waite, manufactured by Novocol Pharmaceutical of Canada Inc. The label indicates the product is a submucosal injection solution for dental block and infiltration anesthesia, available in 50 single-dose cartridges of 1.7 mL each. It includes usage instructions, storage conditions, and regulatory information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.